igf-1 lr3 long term use 1mg | Long-Acting IGF Analogue IGF-1 LR3 Active Protein |

Molecular Identity Comparison Property CJC-1295 (No DAC) Ipamorelin Full Name Modified Growth Hormone Releasing Hormone 1-29 Ipamorelin acetate Amino Acid Count 29 (with 4 amino acid substitutions) 5 (pentapeptide) Molecular Weight ~3367.9 g/mol ~711.9 g/mol Mechanism Class GHRH analog GHRP (Growth Hormone Releasing Peptide) Primary Receptor GHRH-R (Growth Hormone Releasing Hormone Receptor) GHS-R1a (Ghrelin/Growth Hormone Secretagogue Receptor) Research Half-life ~30 minutes (No DAC) / ~8 days (with DAC) ~2 hours The size difference is significant: CJC-1295 is a 29-amino-acid modified hormone fragment, while Ipamorelin is a compact 5-amino-acid synthetic peptide

The patients who respond best to tesamorelin share several characteristics: High visceral fat: The stubborn abdominal fat that sits deep around the organs, not subcutaneous fat just under the skin

A clinician who does not understand sourcing risk cannot responsibly evaluate these peptides at all

Patel, V., & Nguyen, T

10.1016/S0039-128X(99)00037-9 103 MortonR